PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study
Mifen Chen(Peking University), Yinghua Ji(First Affiliated Hospital of Xinxiang Medical University), Guangjie Han(Hebei Medical University), Hui Gao(Jiangnan University), Weifeng Zhao(Guangzhou University of Chinese Medicine), Zimin Liu(Qingdao University), Yong Tang(Xinjiang Medical University), Yongdong Jin(Shenzhen University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Lanxing Li(University of Electronic Science and Technology of China), Fei Yin(Hebei Medical University), Fanghua Song(Dalian University), Xuan Jin(Peking University), Liying Xue(Hebei Medical University), Tong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ya-er Ba(Suizhou Central Hospital), Zhenghang Wang(Peking University), Hongxia Lu(Shanxi Medical University), Zhiwei Chang(First Affiliated Hospital of Zhengzhou University), Wenlei Yang(Peking University), Tiantian Tian(Suzhou Research Institute), Yujuan Cao(Peking University Shougang Hospital), Li Wang(University of Utah), Qing Liu(Central South University), Qi Zhang(Peking University), Na Li(Peter MacCallum Cancer Centre), Xiaodong Wang(Henan Polytechnic University), Yi Li(Qingdao University), Jiayi Li(First Affiliated Hospital of Xiamen University), Qiwei Wang(West Anhui University), Zhiyu Chen(Guiyang Medical University), Ning Liu(Institute of Pomology), Yan Dong(Beijing Luhe Hospital Affiliated to Capital Medical University), Ting Deng(Tianjin Medical University Cancer Institute and Hospital), Yinjie Zhang(Shanxi University), Jingdong Zhang(Liaoning Cancer Hospital & Institute), Hangyu Zhang(Zhejiang University), Qing Wei(Chinese Academy of Sciences), Chunlei Xu(Nanjing University of Chinese Medicine), Xicheng Wang(Shanghai East Hospital), Zhiqiang Cheng(University of Electronic Science and Technology of China), Baoshan Cao(Peking University), Longmei Li(Guangzhou University of Chinese Medicine), Yanhong Yao(Fudan University Shanghai Cancer Center), Zhi Peng(Peking University), Jianling Zou(Zhejiang Cancer Hospital), Zhi Ji(Tianjin Medical University Cancer Institute and Hospital), Huajun Qu(Qingdao University), Xiaotian Zhang(Shanghai University of Traditional Chinese Medicine), Weijia Fang(Zhejiang Cancer Hospital)
Cited by 6
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Iterative (turbo) soft interference cancellation and decoding for coded CDMA
|IEEE Transactions on Communications|1999|1.9k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934